deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT04939038

Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease (DIFU)

Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease: a Randomized, Controlled Trial

Sponsor: Insel Gruppe AG, University Hospital Bern

Conditions Diabetic Foot Ulcer
Interventions Revascularization Standard wound care
Updated 12 times since 2021 Last updated: Dec 16, 2024 Started: Jan 25, 2022 Primary completion: Sep 18, 2024 Completion: Sep 18, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

High pre-screening failure and insufficient recruited patients

Other terminated trials from Insel Gruppe AG, University Hospital Bern

See all terminations from Insel Gruppe AG, University Hospital Bern

Other Diabetic Foot Ulcer trials with similar outcome

Browse all Diabetic Foot Ulcer trials

This NA trial investigates Diabetic Foot Ulcer and is currently terminated or withdrawn. Insel Gruppe AG, University Hospital Bern leads this study, which shows 12 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshotNot Yet Recruiting~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshotRecruiting~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshotRecruiting~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotRecruiting~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshotRecruiting~Mar 2023 – ~Jul 2023 · 4 months · monthly snapshotRecruiting~Jul 2023 – ~Nov 2023 · 4 months · monthly snapshotRecruiting~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotActive Not Recruiting~Jan 2025 – ~Sep 2025 · 8 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Jan 2025 — Sep 2025 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  3. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Nov 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

▶ Show 7 earlier versions

  1. Jul 2023 — Nov 2023 [monthly]

    Recruiting NA

  2. Mar 2023 — Jul 2023 [monthly]

    Recruiting NA

  3. Jan 2023 — Mar 2023 [monthly]

    Recruiting NA

  4. Dec 2022 — Jan 2023 [monthly]

    Recruiting NA

  5. Sep 2022 — Dec 2022 [monthly]

    Recruiting NA

  6. Mar 2022 — Sep 2022 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  7. Sep 2021 — Mar 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Insel Gruppe AG, University Hospital Bern
  • Swiss National Science Foundation
  • University of Bern
Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations